Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytes

被引:37
作者
Borgmann, Kerstin
Haeberle, Doris
Doerk, Thilo
Busjahn, Andreas
Stephan, Gunther
Dikomey, Ekkehard
机构
[1] Univ Hamburg, Med Ctr, Lab Radiobiol & Expt Radiooncol, Clin Radiotherapy & Radiooncol, D-20246 Hamburg, Germany
[2] Hannover Med Sch, Clin Gynecol & Obstet, D-3000 Hannover, Germany
[3] HealthTwiSt GmbH, Berlin, Germany
[4] Fed Off Radiat Protect, Dept Radiat Protect & Hlth, Oberschleissheim, Germany
关键词
individual radiosensitivity; monozygotic twins; G0-assay; G2-assay;
D O I
10.1016/j.radonc.2007.04.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: The radiosensitivity of human lymphocytes measured using a GO- or G2-assay has been linked with an individual's risk of developing normal tissue complications following radiotherapy. This study was performed to increase basic knowledge of the genetics of the human radiation response, and chromosomal aberration induction in particular. Materials and methods: The study was carried out with blood samples taken from 15 monozygotic twin pairs. GO-assay was performed for cells irradiated with 6 Gy counting only deletions and G2-assay for cells irradiated with 0.5 Gy scoring only chromatid breaks. Results: The mean number of deletions measured at 6 Gy for all 30 samples using the GO-assay amounted to 2.96 0.37 (means SID), which corresponds to a coefficient of variation (CV) of 13%. There is a highly significant intra-pair correlation for this number among twins (r(2) = 0.911) demonstrating that this parameter is mostly determined by genetic factors. According to the mean number of deletions, a theoretical classification based on the definition <=MV - SID as resistant, MV SID as normal and >=MV + SID as sensitive was made, identifying two pairs as sensitive or resistant, respectively, while nine were normal and two pairs are intermediate. For chromatid breaks measured at 0. 5 Gy with the G2-assay the mean number was 1.35 +/- 0.42 (means +/- SID) corresponding to a CV of 31%. There was again a strong intrapair correlation among twins with r(2) 0.837 showing that this sensitivity is also determined mostly by genetic factors. There was, however, no inter-assay correlation between the GO- and G2-sensitivity (r(2) = 0.006) demonstrating that these two sensitivities depend on different genetic factors. Conclusion: The chromosomal radiosensitivity of lymphocytes as defined by GO- or G2-assay is largely determined by different genetic factors, which may allow the use of genetic profiling as an indicator of the respective individual radiosensitivity. (C) 2007 Elsevier Ireland Ltd. AU rights reserved.
引用
收藏
页码:196 / 202
页数:7
相关论文
共 51 条
  • [1] Comparison of bleomycin and radiation in the G2 assay of chromatid breaks
    Adema, AD
    Cloos, J
    Verheijen, RHM
    Braakhuis, BJM
    Bryant, PE
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2003, 79 (08) : 655 - 661
  • [2] Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?
    Andreassen, CN
    [J]. ACTA ONCOLOGICA, 2005, 44 (08) : 801 - 815
  • [3] Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition
    Baeyens, A
    Thierens, H
    Claes, K
    Poppe, B
    Messiaen, L
    De Ridder, L
    Vral, A
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (12) : 1379 - 1385
  • [4] Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer
    Barber, JBP
    Burrill, W
    Spreadborough, AR
    Levine, E
    Warren, C
    Kiltie, AE
    Roberts, SA
    Scott, D
    [J]. RADIOTHERAPY AND ONCOLOGY, 2000, 55 (02) : 179 - 186
  • [5] Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition
    Baria, K
    Warren, C
    Eden, OB
    Roberts, SA
    West, CM
    Scott, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2002, 78 (05) : 341 - 346
  • [6] Chromosomal radiosensitivity as a marker of predisposition to common cancers?
    Baria, K
    Warren, C
    Roberts, SA
    West, CM
    Scott, D
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (07) : 892 - 896
  • [7] Becker A, 1997, J REPROD MED, V42, P260
  • [8] Potential clinical impact of normal-tissue intrinsic radiosensitivity testing
    Bentzen, SM
    [J]. RADIOTHERAPY AND ONCOLOGY, 1997, 43 (02) : 121 - 131
  • [9] Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
    Bentzen, Soren M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (09) : 702 - 713
  • [10] BOOSMA D, 2002, NAT REV GENET, V3, P872